Latest Aspirin Stories
The analysis of data from two Swedish registries was presented by Dr Anders Ulvenstam, and suggests that the reduction is due to improvements in AMI care. Ischemic stroke is a well known, relatively rare but potentially devastating complication following myocardial infarction. It can lead to severe neurological handicap and death for the patient and it is associated with great costs for society. "The risk of ischemic stroke after myocardial infarction has been studied previously, but...
Parker Waichman LLP has filed a lawsuit on behalf of a man who experienced hemorrhaging, allegedly due to the use of Plavix (clopidogrel). The lawsuit alleges that Plavix caused the bleeding and claims that the Defendants failed to fully inform users about the risks of taking the blood-thinning medication. New York, NY (PRWEB) August 20, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit against...
Daily aspirin usage is associated with lower overall cancer mortality, but the association may be smaller than what was previously believed, according to a study published August 10 in the Journal of the National Cancer Institute. A recent pooled analysis of randomized trials looking at the effects of daily aspirin use as a preventive measure for vascular events found a significant decrease in overall cancer mortality, of 37%, during a 5-year follow-up analysis, and 15% during a ten-year...
redOrbit Staff & Wire Reports Taking a daily dose of aspirin can help fight off stomach, esophageal or colorectal cancer, claims a new study published in the latest edition of the Journal of the National Cancer Institute. In a study of more than 100,000 healthy individuals who were placed on a daily low-dose aspirin regiment, researchers with the American Cancer Society in Atlanta discovered that the painkilling drug can reduce the risk of developing cancer and slow the spread of...
MISSISSAUGA, ON, July 23, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today is providing an update on the status of its PENNSAID franchise. PENNSAID (diclofenac sodium topical solution) 1.5% w/w U.S. Patent The United States Patent Office has issued Patent # 8,217,078 relating to a method of using PENNSAID (PENNSAID Patent). The PENNSAID Patent expiry...
DENVER, July 17, 2012 /PRNewswire/ -- Big Pharma didn't invent aspirin. Mother Nature did. "Today, most people think of aspirin as a harmless wonder drug -- able to stop pain, fever and even prevent heart attack and stroke, without risk. But that's not true," said The People's Chemist, Shane Ellison, who holds a M.S. degree in organic chemistry and is author of "Over-The-Counter Natural Cures" book. "Thousands of years ago, humans witnessed injured bears gnawing on the bark of...
redOrbit Staff & Wire Reports - Your Universe Online Six months after Excedrin was pulled from store shelves as part of a recall, migraine patients face a difficult dilemma -- try to find an alternative and nearly-as-effective method of treatment, or pay exorbitant prices online for a product that they know can help alleviate the pain caused by their severe headaches. According to Kim Carollo of ABC News, Excedrin was pulled on January 8 -- along with the stimulant No-Doz, the oral...
Parker Waichman LLP has filed a lawsuit on behalf of an Arizona woman who took Plavix (clopidogrel) and suffered from two gastrointestinal hemorrhages. The lawsuit claims that the blood thinner caused the bleeding, along with other serious and permanent injuries. (PRWEB) July 06, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging the use of Plavix caused gastrointestinal hemorrhaging in one...
MORRISTOWN, N.J., June 26, 2012 /PRNewswire/ -- Today, All-Star Major League Baseball (MLB) pitcher CC Sabathia teamed up with the makers of Bayer® Advanced Aspirin to issue the Fast Relief Challenge to help support the American Red Cross and its efforts to provide fast relief to Americans in need. For every person who visits www.FastReliefChallenge.com and clicks on the Red Cross button, the makers of Bayer Advanced Aspirin will donate $2 to the American Red Cross (up to a total...
Many patients with type 2 diabetes may be aspirin resistant. That means the standard aspirin dose may not protect them against blood clots that cause heart attacks and strokes among diabetics, a new clinical study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston. "This result adds to our understanding of the prevalence of this problem, which varies considerably among studies," said lead author Subhashini Yaturu, M.D., section chief of...
